Core vs non-core dog vaccines explained (WSAVA guidelines)

Vaccines are one of the most important tools in preventive veterinary medicine — they have dramatically reduced the incidence of diseases that once killed large numbers of dogs. But not every vaccine is appropriate for every dog. The World Small Animal Veterinary Association (WSAVA) Vaccination Guidelines Group, which publishes the most widely adopted international framework for companion-animal vaccination, draws a clear distinction between core and non-core vaccines.

Core vaccines are recommended for all dogs everywhere, regardless of lifestyle, because the diseases they prevent are severe, potentially fatal, globally present, and/or transmissible to people. Non-core vaccines are recommended only when an individual dog's geographic location, lifestyle or exposure risk justifies them — giving additional protection where there is a genuine local threat. A third category — vaccines not recommended — covers products for which evidence of efficacy is insufficient.

The puppy vaccination schedule (initial series plus first adult booster) is covered in detail in our companion article on the puppy vaccination schedule. This article focuses on the classification framework, the rationale behind core and non-core designations, and what the booster interval evidence says.

Core vaccines: what every dog needs

• Canine Distemper Virus (CDV): a severe, often fatal systemic disease affecting the respiratory, gastrointestinal and nervous systems
• Canine Adenovirus (CAV-2): protects against infectious canine hepatitis (CAV-1) and is a component of kennel cough; a core vaccine because it protects against potentially fatal hepatitis
• Canine Parvovirus (CPV-2): a rapidly fatal viral enteritis, particularly dangerous in puppies; highly resistant in the environment
• Rabies: core globally (required by law for travel and import/export); not routinely required in rabies-free territories such as Singapore for resident pets, but considered core by the WSAVA where the disease is present

Non-core vaccines: based on individual risk

Non-core vaccines are not withheld because they are unsafe or ineffective — they are withheld by default because the risk-benefit calculation depends on exposure. Your vet will assess your dog's lifestyle, travel history, boarding/grooming frequency, and local disease prevalence before recommending any of these.

• Bordetella bronchiseptica + Canine Parainfluenza Virus (kennel cough): recommended for dogs that board, attend daycare, dog parks, or competitions — high social-contact environments
• Canine Influenza Virus (CIV H3N2 / H3N8): relevant where outbreaks are documented; check local veterinary advisory notices
• Leptospira: recommended in regions where leptospirosis is prevalent; transmitted via water and urine of infected animals — relevant in flood-prone tropical areas including parts of Southeast Asia
• Canine Coronavirus (enteric): WSAVA considers evidence insufficient to recommend for general use

Booster intervals: the science has moved on

For many years, annual boosters were standard practice. The WSAVA guidelines, updated with the latest immunological evidence, now recommend that core vaccines — once the puppy series and one-year booster are complete — should generally be given no more frequently than every three years. Studies of duration of immunity show that CDV, CAV and CPV vaccines provide robust protection for three years or longer, and potentially for life in some dogs.

The "every three years" recommendation applies to healthy adult dogs that have completed their primary series. It does not apply to the puppy course, to the 12-month booster, or to non-core vaccines, which may have different duration-of-immunity profiles. Some vets offer titre testing (antibody measurement) to assess whether a dog still has protective immunity before deciding whether to re-vaccinate.

Titre testing as an alternative

Antibody titre testing measures circulating antibody levels for CDV, CAV and CPV. While a positive titre does not guarantee full protection (cellular immunity also matters), WSAVA considers an adequate titre sufficient evidence to defer re-vaccination for core antigens. Titre testing is particularly useful for dogs with a history of vaccine reactions, immunocompromised dogs, and owners who wish to avoid unnecessary vaccines. Costs and test availability vary by country and clinic.

Adverse reactions: rare but real

Vaccine reactions range from mild (lethargy and soreness at the injection site for 24–48 hours — normal and expected) to rare serious reactions including anaphylaxis, immune-mediated conditions, and injection-site sarcomas (the last being more of a concern in cats than dogs). The risk of a serious reaction is very low and is outweighed by protection for core vaccines. Monitoring your dog for one to two hours after vaccination and calling your vet if you notice facial swelling, hives, vomiting or collapse is prudent.